Impaired gastric acidification negatively affects calcium homeostasis and bone mass

Nature Medicine

Volumn 15, Issue 6, 2009, Pages 674-681

  Schinke, Thorsten ^a   Schilling, Arndt F ^a   Baranowsky, Anke ^a   Seitz, Sebastian ^a   Marshall, Robert P ^a   Linn, Tilman ^a   Blaeker, Michael ^b   Huebner, Antje K ^a   Schulz, Ansgar ^c   Simon, Ronald ^b   Gebauer, Matthias ^a   Priemel, Matthias ^a   Kornak, Uwe ^d   Perkovic, Sandra ^a   Barvencik, Florian ^a   Beil, F Timo ^a   Del Fattore, Andrea ^e   Frattini, Annalisa ^f,g   Streichert, Thomas ^b   Pueschel, Klaus ^b   Villa, Anna ^f,g   Debatin, Klaus Michael ^c   Rueger, Johannes M ^a   Teti, Anna ^e   Zustin, Jozef ^b   Sauter, Guido ^b   Amling, Michael ^a   more..

^a Department of Trauma   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY OF L'AQUILA   (Italy)

^f CNR   (Italy)

^g HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CHOLECYSTOKININ RECEPTOR; GLUCONATE CALCIUM; PROTEIN CCKBR; PROTEIN TYROSINE KINASE; PROTON PUMP; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; SRC ENZYME; TCIRG1 ENZYME; UNCLASSIFIED DRUG;

ACIDIFICATION; ALBERS SCHOENBERG DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEFECT; BONE MASS; BONE MINERALIZATION; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CELL ACTIVITY; CONTROLLED STUDY; ENZYME DEFICIENCY; HYPERPARATHYROIDISM; HYPOCALCEMIA; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOPOROSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH PARIETAL CELL; STOMACH PH;

ACIDS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BONE DENSITY; BONE DISEASES, DEVELOPMENTAL; CALCIUM; HOMEOSTASIS; HYDROGEN-ION CONCENTRATION; HYPOCALCEMIA; MICE; MICE, TRANSGENIC; PHENOTYPE; STOMACH; VACUOLAR PROTON-TRANSLOCATING ATPASES;

MUS;

EID: 67349206201     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.1963     Document Type: Article

References (45)

1. Harada, S. & Rodan, G.A. Control of osteoblast function and regulation of bone mass. Nature 423, 349-355 (2003).
2. Teitelbaum, S.L. & Ross, F.P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4, 638-649 (2003).
3. Karaplis, A.C. & Goltzman, D. PTH and PTHrP effects on the skeleton. Rev. Endocr. Metab. Disord. 1, 331-341 (2000).
4. Kaplan, F.S., August, C.S., Fallon, M.D., Gannon, F. & Haddad, J.G. Osteopetrorickets. The paradox of plenty. Pathophysiology and treatment. Clin. Orthop. Relat. Res. 294, 64-78 (1993).
5. Taranta, A. et al. Genotype-phenotype relationship in human ATP6i-dependent auto-somal recessive osteopetrosis. Am. J. Pathol. 162, 57-68 (2003).
6. Kirubakaran, C., Ranjini, K., Scott, J.X., Basker, M. & Sridhar, G. Osteopetrorickets. J. Trop. Pediatr. 50, 185-186 (2004).
7. Del Fattore, A., Cappariello, A. & Teti, A. Genetics, pathogenesis and complications of osteopetrosis. Bone 42, 19-29 (2008).
8. Sly, W.S. et al. Carbonic anhydrase II deficiency in 12 families with the autosomal recessive syndrome of osteopetrosis with renal tubular acidosis and cerebral calcification. N. Engl. J. Med. 313, 139-145 (1985).
9. Kornak, U. et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell 104, 205-215 (2001).
10. Lange, P.F., Wartosch, L., Jentsch, T.J. & Fuhrmann, J.C. ClC-7 requires Ostm1 as a beta-subunit to support bone resorption and lysosomal function. Nature 440, 220-223 (2006).
11. +-ATPases - nature's most versatile proton pumps. Nat. Rev. Mol. Cell Biol. 3, 94-103 (2002).
12. Li, Y.P., Chen, W., Liang, Y., Li, E. & Stashenko, P. Atp6i-deficient mice exhibit severe osteopetrosis due to loss of osteoclast-mediated extracellular acidification. Nat. Genet. 23, 447-451 (1999).
13. Scimeca, J.C. et al. The gene encoding the mouse homologue of the human osteoclastspecific 116-kDa V-ATPase subunit bears a deletion in osteosclerotic (oc/oc) mutants. Bone 26, 207-213 (2000).
14. Marks, S.C. Jr., Seifert, M.F. & Lane, P.W. Osteosclerosis, a recessive skeletal mutation on chromosome 19 in the mouse. J. Hered. 76, 171-176 (1985).
15. Frattini, A. et al. Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis. Nat. Genet. 25, 343-346 (2000).
16. +-ATPase cause infantile malignant osteopetrosis. Hum. Mol. Genet. 9, 2059-2063 (2000).
17. Sobacchi, C. et al. The mutational spectrum of human malignant autosomal recessive osteopetrosis. Hum. Mol. Genet. 10, 1767-1773 (2001).
18. Del Fattore, A. et al. Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment. J. Med. Genet. 43, 315-325 (2006).
19. Banco, R., Seifert, M.F., Marks, S.C. Jr. & McGuire, J.L. Rickets and osteopetrosis: the osteosclerotic (oc) mouse. Clin. Orthop. Relat. Res. 201, 238-246 (1985).
20. Li, Y.P., Chen, W. & Stashenko, P. Molecular cloning and characterization of a putative novel human osteoclast-specific 116-kDa vacuolar proton pump subunit. Biochem. Biophys. Res. Commun. 218, 813-821 (1996).
21. Soriano, P., Montgomery, C., Geske, R. & Bradley, A. Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64, 693-702 (1991).
22. Langhans, N. et al. Abnormal gastric histology and decreased acid production in cholecystokinin-B/gastrin receptor-deficient mice. Gastroenterology 112, 280-286 (1997).
23. 3- exchanger are achlorhydric. J. Biol. Chem. 279, 30531-30539 (2004).
24. Wilson, C.J. & Velodi, A. Autosomal recessive osteopetrosis: diagnosis, management, and outcome. Arch. Dis. Child. 83, 449-452 (2000).
25. Driessen, G.J. et al. Long-term outcome of haematopoietic stem cell transplantation in autosomal recessive osteopetrosis: an EBMT report. Bone Marrow Transplant. 32, 657-663 (2003).
26. Frattini, A. et al. Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. J. Bone Miner. Res. 18, 1740-1747 (2003).
27. Kasper, D. et al. Loss of the chloride channel ClC-7 leads to lysosomal storage disease and neurodegeneration. EMBO J. 24, 1079-1091 (2005).
28. Pangrazio, A. et al. Mutations in OSTM1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement. J. Bone Miner. Res. 21, 1098-1105 (2006).
29. Chalhoub, N. et al. Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human. Nat. Med. 9, 399-406 (2003).
30. Kassarjian, Z. & Russell, R.M. Hypochlorhydria: a factor in nutrition. Annu. Rev. Nutr. 9, 271-285 (1989).
31. Aoki, K. et al. Comparison of prevalence of chronic atrophic gastritis in Japan, China, Tanzania, and the Dominican Republic. Ann. Epidemiol. 15, 598-606 (2005).
32. Jacobson, B.C. et al. Who is using chronic acid suppression therapy and why? Am. J. Gastroenterol. 98, 51-58 (2003).
33. Recker, R.R. Calcium absorption and achlorhydria. N. Engl. J. Med. 313, 70-73 (1985).
34. O'Connell, M.B., Madden, D.M., Murray, A.M., Heaney, R.P. & Kerzner, L.J. Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomized crossover trial. Am. J. Med. 118, 778-781 (2005).
35. Yang, Y.-X., Lewis, J.D., Epstein, S. & Metz, D.C. Long-term proton pump inhibitor therapy and risk of hip fracture. J. Am. Med. Assoc. 296, 2947-2953 (2006).
36. Cummings, S.R. & Melton, L.J. Epidemiology and outcomes of osteoporotic fractures. Lancet 359, 1761-1767 (2002).
37. Straub, D.A. Calcium supplementation in clinical practice: a review of forms, doses, and indications. Nutr. Clin. Pract. 22, 286-296 (2007).
38. Seitz, S. et al. Paget's disease of bone - histologic analysis of 754 patients. J. Bone Miner. Res. 24, 62-69 (2009).
39. Parfitt, A.M. et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J. Bone Miner. Res. 2, 595-610 (1987).
40. Huebner, A.K. et al. Calcitonin deficiency in mice progressively results in high bone turnover. J. Bone Miner. Res. 21, 1924-1934 (2006).
41. Hoff, A.O. et al. Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene. J. Clin. Invest. 110, 1849-1857 (2002).
42. Schmidt, K. et al. The high mobility group transcription factor Sox8 is a negative regulator of osteoblast differentiation. J. Cell Biol. 168, 899-910 (2005).
43. Amling, M. et al. Bcl-2 lies downstream of parathyroid hormone-related peptide in a signaling pathway that regulates chondrocyte maturation during skeletal development. J. Cell Biol. 136, 205-213 (1997).
44. Simon, R., Mirlacher, M. & Sauter, G. Tissue microarrays. Biotechniques 36, 98-105 (2004).
45. Takagi, H., Jhappan, C., Sharp, R. & Merlino, G. Hypertrophic gastropathy resembling Ménétrier's disease in transgenic mice overexpressing transforming growth factor alpha in the stomach. J. Clin. Invest. 90, 1161-1167 (1992).\